Cardiologists at University of Utah Health use this therapy for people with heart rhythm disorders (arrhythmias), including atrial flutter and atrial fibrillation (AFib). Your heart’s electrical ...
The 204 people randomized to IV procainamide (plus electrical cardioversion if necessary, with up to three shocks) showed a 96% rate of conversion to sinus rhythm that was maintained for at least 30 ...
San Diego-based Maxwell Biomedical announced this morning that it has acquired Cardialen, a Minneapolis-based company that develops a low-energy defibrillation and cardioversion therapy designed to ...
Aside from patient factors, a number of factors may influence the immediate success of cardioversion, that is, a complete failure to cardiovert. These include electrode placement, shock polarity, ...
PHILADELPHIA, PA—For patients with obesity who are undergoing electrical cardioversion for atrial fibrillation (AF), delivering twice the energy with a simultaneous dual approach is a better option ...
MINNEAPOLIS--(BUSINESS WIRE)--Cardialen, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin a clinical trial of its ...
PHILADELPHIA -- For atrial fibrillation (Afib) patients with obesity, a second set of defibrillation pads for dual direct current cardioversion safely improved the success of the procedure, a ...
A small series provides provocative new data on the safety of performing direct current cardioversion (DCCV) without oral anticoagulation in high-risk patients with a Watchman left atrial appendage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback